Serological Study of COVID-19 Antibodies

Participants were invited via letter including a personal access code; individuals that agreed to take part in the study signed a written informed consent and used their personal code to access online registration for the study visit. In case of study-related questions or technical issues, a hotline service was available. Online questionnaires were available from January 18th to February 6th^, 2021. For participants that encountered difficulties in filling out the online questionnaires, study staff were available during the study visit to assist them. Study visits took place in one center located in Lausanne between February 1st and February 6th 2021, during which a locally developed serological test was administered, a Luminex assay detecting anti-SARS-CoV-2 IgG and IgA antibodies [24 (link)]. In case participants were unable to attend the study visit on-site, a home visit was possible by means of four mobile study teams. All data were collected and managed using the Research Electronic Data Capture (REDCap) tools hosted at Unisanté. REDCap is a secure, web-based software platform designed to support data capture for research studies [25 (link)].

Free full text: Click here

Veys-Takeuchi C., Gonseth Nusslé S., Estoppey S., Zuppinger C., Dupraz J., Pasquier J., Faivre V., Scuderi R., Vassaux S., Bochud M, & D’Acremont V. (2022). Determinants of COVID-19 Vaccine Hesitancy During the Pandemic: A Cross-Sectional Survey in the Canton of Vaud, Switzerland. International Journal of Public Health, 67, 1604987.

Publication 2022

Research Electronic Data Capture (REDCap)

Anti igg Assay Hotline Iga antibodies Sars cov 2 Serological test

Corresponding Organization :

Other organizations : Alliance for Health Policy and Systems Research, Swiss Tropical and Public Health Institute

Top 5 similar protocols

Variable analysis

independent variables

Method of invitation (via letter including a personal access code)
Availability of a hotline service for study-related questions or technical issues
Availability of study staff to assist participants with filling out online questionnaires
Location of study visits (one center in Lausanne)
Timing of online questionnaires (January 18th to February 6th, 2021)
Timing of study visits (February 1st to February 6th, 2021)
Availability of home visits by mobile study teams

dependent variables

Participation in the study (signing a written informed consent and using the personal code to access online registration)
Completion of online questionnaires
Attendance of study visit
Results of the locally developed serological test
Results of the Luminex assay detecting anti-SARS-CoV-2 IgG and IgA antibodies

control variables

Use of the Research Electronic Data Capture (REDCap) tools hosted at Unisanté to collect and manage all data

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!